Department of Biomedicine🔬🧪

@biomedizin.unibas.ch

As a joint venture of the University of Basel and the University Hospitals Basel, the Department of Biomedicine (DBM) brings together basic and clinical scientists to advance our understanding of health and disease.

@biomedizin.unibas.ch

Congratulations to Gregor Hutter on his appointment as Clinical Professor of Neurosurgery at @unibas.ch. At @biomedizin.unibas.ch, @hutterlab.bsky.social studies how immune cells can be harnessed against glioblastoma and develops new therapies. Congratulations, Gregor! 🎉

Professor Gregor Hutter.
@biomedizin.unibas.ch

🎉Congratulations to David Bargiela on his @snsf.ch Ambizione Grant! His new project investigates how glioblastoma cells survive treatment and adapt their metabolism following immune attack – with the aim of identifying vulnerabilities that could improve responses to immunotherapies! What a success!

@biomedizin.unibas.ch

A new way to turn the tumor microenvironment against cancer: Researchers from Cambridge and Basel developed small molecules that make macrophages engulf cancer cells while reducing PD-L1-mediated immune suppression. Published in Cancer Research.

👇Publication link below.

#CancerResearch

Green-stained macrophages engulf red-labeled cancer cells after treatment with PSEs. The red signal inside the macrophages shows that they have taken up cancer cells. (Image: Valerio Sabatino, University of Basel)
@biomedizin.unibas.ch

Mini-tumors help uncover new treatment options for liver cancer. Researchers led by Markus Heim and Sandro Nuciforo from @biomedizin.unibas.ch screened >1,600 compounds in patient-derived organoids and identified promising drug combinations that work across diverse tumors. 👇